TECHNOLOGY SUMMARY

Current state of the art technologies for CNS disease mechanism studies and drug discovery include rodent models. These models are failing in their predictive capacity in translational medicine applications. Our proprietary human neural organoid models yield clinically corroborated results of opioid use disorders and novel therapeutic drugs identified.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Commercial Product

Technology Readiness Level: TRL 7

Vetted Programs/Awards: SBIRs

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Website: http://neurxstem.com/

Showcase Booth: 524T

MARKET KEYWORDS

Market Keywords: Diagnostics, Therapeutics, Addiction